Renoprotective effect of COMP-angiopoietin-1 in db/db mice with type 2 diabetes

被引:65
作者
Lee, Sik
Kim, Won
Moon, Sang-Ok
Sung, Mi Jeong
Kim, Duk Hoon
Kang, Kyung Pyo
Jang, Kyu Yoon
Lee, Sang Yong
Park, Byung Hyun
Koh, Gou Young
Park, Sung Kwang
机构
[1] Chonnam Natl Univ, Sch Med, Dept Internal Med, Jeonju 561712, South Korea
[2] Chonnam Natl Univ, Sch Med, Dept Pathol, Jeonju 561712, South Korea
[3] Chonnam Natl Univ, Sch Med, Dept Radiol, Jeonju 561712, South Korea
[4] Chonnam Natl Univ, Sch Med, Dept Biochem, Renal Regenerat Lab,Res Inst Clin Med, Jeonju 561712, South Korea
[5] Korea Adv Inst Sci & Technol, Biomed Res Ctr, Taejon 305701, South Korea
[6] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea
关键词
COMP-angiopoietin-1; diabetic db/db mouse; inflammation; kidney;
D O I
10.1093/ndt/gfl598
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background. Inflammatory processes have been recently seen as underlying the pathogenesis of diabetic nephropathy. Angiopoietin-1 (Ang1) plays essential roles in regulating vascular growth, development, maturation, permeability and inflammation. We have developed a soluble, stable and potent Ang1 variant, cartilage oligomeric matrix protein (COMP)-Ang1. Methods. In this study, db/db mice were treated with recombinant adenovirus expressing either COMP-Ang1 or LacZ. Histology, inflammatory, metabolic, and fibrotic parameters and signalling pathway were evaluated. Results. COMP-Ang1 reduced albuminuria and decreased mesangial expansion, thickening of the glomerular basement membrane and podocyte foot process broadening and effacement. COMP-Ang1 suppressed both renal expression of intercellular adhesion molecule-1 and monocyte chemoattractant protein-1 and monocyte/macrophage infiltration in diabetic db/db mice. COMP-Ang1 also reduced renal tissue levels of transforming growth factor-beta 1 (TGF-beta 1), alpha-smooth muscle actin, fibronectin, as well as Smad 2/3 expression, but increased Smad 7 expression. In human umbilical vein endothelial cells (HUVECs) grown in high glucose concentrations of glucose, recombinant COMP-Ang1 protein decreased nuclear factor-kappa B (NF-kappa B) expression. COMP-Ang1-mediated inhibition of increased NF-kappa B-DNA binding in nuclear extracts from HUVECs grown in high glucose was significantly blocked by soluble Tie2 receptor-Fc. In addition, COMP-Ang1 significantly decreased fasting blood glucose level, epididymal fat weight to body weight ratio, and epididymal adipocyte size in diabetic db/db mice. After intraperitoneal glucose challenge, COMP-Ang1 significantly lowered plasma glucose levels. However, there was no difference in serum insulin levels. Conclusion. We conclude that COMP-Ang1 delayed the fibrotic changes in the kidney of diabetic db/db mice through its anti-inflammatory or metabolic effects.
引用
收藏
页码:396 / 408
页数:13
相关论文
共 20 条
[1]   Advanced glycation end products and the kidney [J].
Bohlender, JM ;
Franke, S ;
Stein, G ;
Wolf, G .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2005, 289 (04) :F645-F659
[2]  
Chen HC, 2002, J LIPID RES, V43, P986
[3]   Long-term and sustained COMP-Ang1 induces long-lasting vascular enlargement and enhanced blood flow [J].
Cho, CH ;
Kim, KE ;
Byun, J ;
Jang, HS ;
Kim, DK ;
Baluk, P ;
Baffert, F ;
Lee, GM ;
Mochizuki, N ;
Kim, J ;
Jeon, BH ;
McDonald, DM ;
Koh, GY .
CIRCULATION RESEARCH, 2005, 97 (01) :86-94
[4]   COMP-Ang1: A designed angiopoietin-1 variant with nonleaky angiogenic activity [J].
Cho, CH ;
Kammerer, RA ;
Lee, HJ ;
Steinmetz, MO ;
Ryu, YS ;
Lee, SH ;
Yasunaga, K ;
Kim, KT ;
Kim, I ;
Choi, HH ;
Kim, W ;
Kim, SH ;
Park, SK ;
Lee, GM ;
Koh, GY .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (15) :5547-5552
[5]   Designed angiopoietin-1 variant, COMP-Ang1, protects against radiation-induced endothelial cell apoptosis [J].
Cho, CH ;
Kammerer, RA ;
Lee, HJ ;
Yasunaga, K ;
Kim, KT ;
Choi, HH ;
Kim, W ;
Kim, SH ;
Park, SK ;
Lee, GM ;
Koh, GY .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (15) :5553-5558
[6]   Intercellular adhesion molecule-1 deficiency is protective against nephropathy in type 2 diabetic db/db mice [J].
Chow, FY ;
Nikolic-Paterson, DJ ;
Ozols, E ;
Atkins, RC ;
Tesch, GH .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (06) :1711-1722
[7]   Leukocyte recruitment and vascular injury in diabetic nephropathy [J].
Galkina, Elena ;
Ley, Klaus .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 17 (02) :368-377
[8]   The antiinflammatory endothelial tyrosine kinase tie2 interacts with a novel nuclear factor-κB inhibitor ABIN-2 [J].
Hughes, DP ;
Marron, MB ;
Brindle, NPJ .
CIRCULATION RESEARCH, 2003, 92 (06) :630-636
[9]   Suppression of diabetic retinopathy with angiopoietin-1 [J].
Joussen, AM ;
Poulaki, V ;
Tsujikawa, A ;
Qin, WY ;
Qaum, T ;
Xu, QW ;
Moromizato, Y ;
Bursell, SE ;
Wiegand, SJ ;
Rudge, J ;
Ioffe, E ;
Yancopoulos, GD ;
Adamis, AP .
AMERICAN JOURNAL OF PATHOLOGY, 2002, 160 (05) :1683-1693
[10]   Angiopoietin-1 reduces VEGF-stimulated leukocyte adhesion to endothelial cells by reducing ICAM-1, VCAM-1, and E-selectin expression [J].
Kim, I ;
Moon, SO ;
Park, SK ;
Chae, SW ;
Koh, GY .
CIRCULATION RESEARCH, 2001, 89 (06) :477-479